Bücher

  1. Zouboulis CC (1995) Morbus Adamantiades-Behçet: Klinische und experimentelle Untersuchungen - Erhebungen an 53 Patienten aus dem Berliner Raum. Habilitationsschrift, Fachbereich Humanmedizin der Freien Universität Berlin
  2. Zouboulis CC (ed) Adamantiades-Behçet's Disease. Springer, Heidelberg Berlin, 2003 (ISBN 978-0-306-47757-7)

 

Originalpublikationen

  1. Dührsen U, Kirch W, Brittinger G, Ohnhaus EE, Reinwein D (1984) [The Behçet syndrome. Report on 12 cases and overview of the literature]. Schweiz Med Wochenschr 114:1058-1068
  2. Dührsen U, Kirch W (1985) [Diagnosis of Behçet's syndrome]. Dtsch Med Wochenschr 110:264-267
  3. Dührsen U, Kirch W (1985) [Therapy of Behçet's syndrome]. Dtsch Med Wochenschr 110:267-270
  4. Dührsen U, Kirch W (1986) Therapeutic rounds. Clin Ther 8:380-381, 459-460
  5. Raedler A, Bredow G, Kirch W, Thiele HG, Greten H (1986) In vivo activated peripheral T cells in autoimmune disease. J Clin Lab Immunol 19:181-186
  6. Kirch W, Dührsen U (1990) [Behçet's syndrome: treatment with recombinant interferon gamma]. Dtsch Med Wochenschr 115:357
  7. Kirch W, Dührsen U (1990) [Treatment of Behçet's syndrome with azathioprine]. Dtsch Med Wochenschr 115:1126-1127
  8. Schilling H, Bornfeld N, Windeck R, Wessing A, Kirch W (1990) [Cytostatic and immunosuppressive treatment of ocular Behçet syndrome]. Klin Monatsbl Augenheilkd 196:62-69
  9. Zouboulis CC, Kurz K, Bratzke B, Orfanos CE (1991) Morbus Adamantiades-Behçet. Nekrotisierende Systemvaskulitis mit letalem Ausgang. Hautarzt 42:451-454
  10. Zouboulis CC, Büttner P, Djawari D, Kirch W, Keitel W, Garbe C, von Keyserlingk-Eberius H-J, Orfanos CE (1993) HLA-Muster bei Morbus Adamantiades-Behçet in Deutschland: Assoziation zum Auftreten, der klinischen Symptomatik und dem Krankheitsverlauf bei 39 Patienten. Hautarzt 44:81-85 & Erratum 44:256
  11. Zouboulis CC, Büttner P, Tebbe B, Orfanos CE (1993) Anticardiolipin antibodies in Adamantiades-Behçet’s disease. Br J Dermatol 128:281-284
  12. Zouboulis CC, Treudler R, Orfanos CE (1993) Morbus Adamantiades-Behçet: therapeutischer Einsatz von systemischem rekombinanten Interferon-alpha-2a. Hautarzt 44:440-445
  13. Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R, Gaffney K, Mat C, Yazici H, Al Ialaan A, Assad-Khalil SH, Kaneko F, Jorizzo EAF (1995) Mucocutaneous criteria for the diagnosis of Behçet’s disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 32:968-976
  14. Zierhut M, Saal J, Pleyer U, Kötter I, Dürk H, Fierlbeck G (1995) Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patients. Ger J Ophthalmol 4:246-251
  15. Jockers-Scherübl MC, Zouboulis CC, Boegner F, Hellweg R (1996) Is nerve growth factor a serum marker for neurological and psychiatric complications in Behçet’s disease? Lancet 347:982
  16. Kötter I, Dürk H, Saal JG, Eckstein A, Zierhut M, Fierlbeck G (1996) Morbus Behçet. Dtsch Med Wochenschr 121:382-388
  17. Kötter I, Dürk H, Eckstein A, Zierhut M, Fierlbeck G, Saal JG (1996) Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma. Clin Exp Rheumatol 14:313-315
  18. Kötter I, Dürk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M (1996) Therapy of Behçet's disease. Ger J Ophthalmol 5:92-97
  19. Treudler R, Zouboulis CC, Büttner P, Detmar M, Orfanos CE (1996) Enhanced interaction of patients’ lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behçet’s disease. Arch Dermatol 132:1323-1329
  20. Zouboulis CC (1996) Morbus Adamantiades-Behçet in Deutschland: Historischer Rückblick und aktueller Kenntnisstand. Z Hautkr 71:491-501
  21. Eschrich S, Zouboulis CC, Schweiger U, Riess H, Huhn D (1997) Beckenvenenthrombose trotz antikoagulatorischer Therapie bei einem 17jährigen Patienten. Internist 38:77-80
  22. Krüger K, Fritz K, Daniel V, Zouboulis CC (1997) Juveniler Morbus Adamantiades-Behçet bei erniedrigter Stimulation mit Anti-CD3 monoklonalem Antikörper. Hautarzt 48:258-261
  23. Siepmann M, Kirch W (1997) Coronary anomaly in Behçet's syndrome. Rheumatol Int 17:39-42
  24. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stadler R, Wollina U, Proksch E, Söhnchen R, Weber H, Gollnick HPM, Hölzle E, Fritz K, Licht T, Orfanos CE (1997) Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J 38:411-422
  25. Dippel E, Zouboulis CC, Tebbe B, Orfanos CE (1998) Myopathic syndrome associated with long-term recombinant interferon alfa treatment in 4 patients with skin disorders. Arch Dermatol 134:880-881Eichhorn A, Kirch W (1998) [Sicca symptoms and hearing loss in Behçet's syndrome]. Dtsch Med Wochenschr 123:663-666
  26. Kaatz M, Görnig M, Bocker T, Zouboulis CC, Wollina U (1998) Spätmanifestation eines Morbus Adamantiades-Behçet mit kardialer Beteiligung und letalem Ausgang. Dtsch med Wschr 123:217-222
  27. Kötter I, Eckstein AK, Stübiger N, Zierhut M (1998) Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol 82:488-494
  28. Zouboulis CC, Orfanos CE (1998) Treatment of Adamantiades-Behçet’s disease with systemic interferon alfa. Arch Dermatol 134:1010-1016
  29. Meljanac N, Dippel E, Zouboulis CC (1999) Superimposed primary chancre in a patient with Adamantiades-Behçet’s disease. Sex Transm Infect 75:124-125
  30. Treudler R, Orfanos CE, Zouboulis CC (1999) Twenty eight cases of juvenile-onset Adamantiades-Behçet’s disease in Germany. Dermatology 199:15-19
  31. Zouboulis CC (1999) Epidemiology of Adamantiades-Behçet’s disease. Ann Med Interne 150:488-498
  32. Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC (2000) Adamantiades-Behçet’s disease: Serum IL-8 is a more reliable marker for disease activity than c-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37-39Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis Ph, Orfanos CE (2000) Adamantiades-Behçet’s disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279-284
  33. Adler YD, Mansmann U, Zouboulis CC (2001) Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Dermatology 203:322-324
  34. Kötter I, Aepinus C, Graepler F, Gärtner V, Eckstein AK, Stübiger N, Kaskas B, Zierhut M, Bültmann B, Kandolf R, Kanz L (2001) HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha. Ann Rheum Dis 60:83-86
  35. Kötter I, Günaydin I, Stübiger N, Yazici H, Fresko I, Zouboulis CC, Adler Y, Steiert I, Kurz B, Wernet D, Braun B, Müller CA (2001) Comparative analysis of the association of HLA-B*51x and its suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens 58:166-170
  36. Stübiger N, Kötter I, Deuter C, Zierhut M (2001) [Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical
    study in 33 patients].     Klin Monatsbl Augenheilkd 218:768-773
  37. Adler YD, Jovanovic S, Jivanjee A, Krause L, Zouboulis CC (2002) Adamantiades-Behçet's disease with inner ear involvement. Clin Exp Rheumatol 20 (suppl 26):S40-S42Zouboulis CC (2002) Benediktos Adamantiades and his forgotten contributions to medicine. Eur J Dermatol 12:471-474
  38. Zouboulis CC, Keitel W (2002) A historical review of early descriptions of Adamantiades-Behçet's disease. J Invest Dermatol 119:201-205
  39. Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis CC (2003) Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology 206:225-232
  40. Keitel W, Zouboulis CC (2003) Adamantiades und Behçet, der Grieche und der Türke. Z Rheumatol 62:88-94
  41. Kötter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stübiger N (2003) Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87:423-431
  42. Krause L, Hoffmann F, Zouboulis ChC, Foerster MH (2003) Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behcet's disease: a case report. Graefes Arch Clin Exp Ophthalmol 241:871-874
  43. Zouboulis CC, Kaklamanis P (2003) Early descriptions of Adamantiades-Behçet's disease. Ann Rheum Dis 67:691-692
  44. Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 192:149-155
  45. Zouboulis CC, Turnbull JR, Mühlradt PF (2003) High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol 121:211-212
  46. Zouboulis CC, Vaiopoulos G, Marcomichelakis N, Palimeris G, Markidou I, Thouas B, Kaklamanis P (2003) Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece. Clin Exp Rheumatol 21(suppl 30):S19-S26
  47. Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N (2004) [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a]. Ophthalmologe 101:129-134
  48. Kötter I (2004) The occurrence of Kaposi's sarcoma (KS) in rheumatic diseases. Semin Arthritis Rheum 33:352
  49. Kötter I, Günaydin I, Zierhut M, Stübiger N (2004) The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum 33:320-335
  50. Kötter I, Vonthein R, Müller CA, Günaydin I, Zierhut M, Stübiger N (2004) Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133-139
  51. Kötter I, Vonthein R, Zierhut M, Eckstein AK, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Stübiger N (2004) Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial. Semin Arthritis Rheum 33:311-319
  52. Treusch M, Vonthein R, Baur M, Günaydin I, Koch S, Stübiger N, Eckstein AK, Peter HH, Ness T, Zierhut M, Kötter I (2004) Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford) 43:1275-1282
  53. Zouboulis CC (2004) Extended venous thrombosis in Adamantiades-Behçet's disease. Eur J Dermatol 14:268-271
  54. Kötter I, Deuter C, Stubiger N, Zierhut M (2005) Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN. J Rheumatol 32:1633
  55. Kötter I, Koch S, Vonthein R, Rückwaldt U, Amberger M, Günaydin I, Zierhut M, Stübiger N (2005) Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 23(suppl 38):S20-26
  56. Krause L (2005) Morbus Adamantiades-Behçet. Ophthalmologe 102:329-334
  57. Altenburg A, Papoutsis N, Orawa H, Martus P, Zouboulis CC (2006) Epidemiologie und Klinik des Morbus Adamantiades-Behçet in Deutschland - Aktuelle pathogenetische Konzepte und therapeutische Möglichkeiten. J Dtsch Dermatol Ges 4:49-68
  58. Altenburg A, Papoutsis N, Orawa H, Martus P, Zouboulis CC (2006) Morbus Adamantiades-Behçet: Epidemiologie, pathogenetische Konzepte und therapeutische Möglichkeiten. Akt Dermatol 32:360-364
  59. Kötter I (2006) The magic of syndromes. Clin Exp Rheumatol 24(suppl 42):S56-57
  60. Kötter I, Deuter C, Günaydin I, Zierhut M (2006) MAGIC or not MAGIC - Does the MAGIC (mouth and genital ulcers with inflamed cartilage) syndrome really exist? A case report and review of the literature. Clin Exp Rheumatol 24(suppl 42):S108-112 (Erratum in: Clin Exp Rheumatol 2007;25:507-508)
  61. Kötter I, Günaydin I, Batra M, Vonthein R, Stübiger N, Fierlbeck G, Melms A (2006) CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases. Clin Rheumatol 25:482-486
  62. Papoutsis NG, Abdel-Naser MB, Altenburg A, Orawa H, Kötter I, Krause L, Pleyer U, Djawari D, Stadler R, Wollina U, Kohl P, Gollnick HPM, Kirch W, Ochsendorf FR, Keitel W, Martus P, Zouboulis CC (2006) Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: Results of a nationwide survey. Clin Exp Rheumatol 24 (Suppl 42):S215 & (2007) 25:507-508
  63. Zouboulis CC (2006) HLA-independent anti-bacterial host response toward Th1-immunity mediated by IL-12: A new concept for the pathogenesis of Adamantiades-Behçet's disease. J Invest Dermatol 126:1444-1447
  64. Alpsoy E, Zouboulis CC, Ehrlich GE (2007) Mucocutaneous lesions of Behçet's disease. Yonsei Med J 48:573-585
  65. Altenburg A, Abdel-Naser B, Abdallah M, Seeber H, Zouboulis CC (2007) Practical aspects of management of recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol 21:1019-1026
  66. Amberger M, Groll S, Günaydin I, Deuter C, Vonthein R, Kötter I (2007) Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis - Influence of treatment with interferon-alpha2a. Clin Exp Rheumatol 25(Suppl 45):S52-57
  67. Daikeler T, Kötter I, Bocelli Tyndall C, Apperley J, Attarbaschi A, Guardiola P, Gratwohl A, Jantunen E, Marmont A, Porretto F, Musso M, Maurer B, Rinaldi N, Saccardi R, Tyndall A; EBMT Autoimmune Diseases Working Party. (2007) Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis 66:202-207
  68. Kalayciyan A, Orawa H, Fimmel S, Perschel FH, González J-B, Fitzner RG, Orfanos CE, Zouboulis CC (2007) Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behçet's disease. J Invest Dermatol 127:81-89
  69. Kalayciyan A, Zouboulis CC (2007) An update on Behçet's disease. J Eur Acad Dermatol Venereol 21:1-10
  70. Krause L, Altenburg A, Bechrakis NE, Willerding G, Zouboulis CC, Foerster MH (2007) Intraocular surgery under systemic interferon alpha therapy in ocular Adamantiades-Behçet´s disease. Graefe's Arch Clin Exp Ophthalmol 245:1617-1621
  71. Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis CC, Kaklamanis P, Yazici H (2007) Anti-TNF therapy in the management of Behçet's disease: Review and basis for recommendations. Rheumatology (Oxford) 46:736-741
  72. Thomas C, Kötter I, Aschoff P, Horger M (2007) Vasculo-Behcet's disease: imaging findings. Rofo 179:875-878
  73. Willerding G, Heimann H, Zouboulis CC, Krause L (2007) Acute central retinal artery occlusion in Adamantiades-Behçet disease. Eye 21:1006-1007
  74. Altenburg A, Zouboulis CC (2008) Current concepts in the treatment of recurrent aphthous stomatitis. Skin Therapy Lett 13 (7):1-4
  75. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H; EULAR Expert Committee (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67:1656-1662
  76. Deuter CM, Kötter I, Wallace GR, Murray PI, Stübiger N, Zierhut M (2008) Behçet's disease: ocular effects and treatment. Prog Retin Eye Res 27:111-136
  77. Horger M, Maksimovic O, Kötter I, Ernemann U (2008) Neuro-Behçet: MRT-Befunde. Rofo 180:691-697
  78. Krause L, Altenburg A, Köhler A-K, Pleyer U, Zouboulis CC, Foerster MH (2008) Long - term visual prognosis of ocular Adamantiades-Behçet's disease treated with Interferon-alfa-2a. J Rheumatol 35:896-903
  79. Kümmerle-Deschner JB, Tzaribachev N, Deuter C, Zierhut M, Batra M, Koetter I (2008) Interferon-alpha--a new therapeutic option in refractory juvenile Behçet's disease with CNS involvement. Rheumatology (Oxford) 47:1051-1053
  80. Storz K, Löffler J, Koch S, Vonthein R, Altenburg A, Zouboulis CC, Fresko I, Yazici H, Kötter I (2008) IL-6 receptor, IL-8 receptor and TNF 238(G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin. Clin Exp Rheumatol 26(suppl 50):S103-S106
  81. Altenburg A, Krahl D, Zouboulis CC. Non-infectious ulcerating oral mucous membrane diseases. J Dtsch Dermatol Ges 2009; 7:242-57
  82. Bonitsis NG, Altenburg A, Krause L, Stache T, Zouboulis CC (2009) Current concepts in the treatment of Adamantiades-Behçet's disease. Drugs Fut 34:749-763
  83. Dejaco C, Duftner C, Calamia KT, Schirmer M (2009) 13th International Conference on Behçet's Disease, May 24-27, 2008, Pörtschach am Wörthersee, Austria. J Rheumatol 36:1312-1317
  84. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H (2009) Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis 68:1528-1534
  85. Hoxha FT, Hashani S, Krasniqi A, Pllana M, Komoni D, Pustina B, Sopa R, Zouboulis CC (2009) Intestinal vasculitis in Adamantiades-Behçet disease presenting as acute abdomen. J Eur Acad Dermatol Venereol 23:1461-1463
  86. Kötter I (2009) Empfehlungen der EULAR für die Therapie des Morbus Behçet. Bericht einer Arbeitsgruppe der European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Z Rheumatol 68:157-161
  87. Kötter I (2010) Behandlung des Morbus Behçet. Eine systematische Übersicht der Literatur für die evidenzbasierten Empfehlungen zur Therapie des M. Behçet der EULAR. Z Rheumatol 69:658-659
  88. Krause L, Köhler A-K, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, Stroux A, Foerster MH (2009) Epidemiology of ocular involvement in Adamantiades-Behçet's disease in Berlin, Germany. Graefes Arch Clin Exp Ophthalmol 247:661-666
  89. Krause L, Köhler A-K, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, Stroux A, Foerster MH (2009) Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease. Eye 23:1182-1186
  90. Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I (2010) Long-term remission after cessation of interferon-a treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum 62:2796-2805
  91. Kötter I (2010) Die Behandlung des Morbus Behçet: Eine systematische Literaturübersicht zur Behandlung des Morbus Behçet für die evidenzbesierten Empfehlungen der European League Against Rheumatism. Z Rheumatol 69:658-659
  92. Kötter I, Hamuryudan V, Oztürk ZE, Yazici H (2010) Interferon therapy in rheumatic diseases: state-of-the-art 2010. Curr Opin Rheumatol 22:278-283
  93. Zouboulis CC (2010) Der Morbus Adamantiades-Behçet und seine Geschichte. Akt Dermatol 36:18-22
  94. Zouboulis CC, Grzybowski A (2010) The upright name of the disorder: Adamantiades-Behçet's Disease. Med Sci Monit 16:LE19-20
  95. Calamia KT, Schirmer M, Melikoglu M (2011) Major vessel involvement in Behçet's disease: an update. Curr Opin Rheumatol 23:24-31

 

Buchbeiträge

  1. Orfanos CE, Garbe C in Kooperation mit Tebbe B, Zouboulis CC, Blume-Peytavi U, Gollnick H (1995) Therapie der Hautkrankheiten einschließlich Andrologie, Phlebologie, Proktologie, pädiatrische Dermatologie, tropische Dermatosen und Venerologie. Springer, Berlin Heidelberg New York
  2. Zouboulis CC (1999) Adamantiades-Behçet’s disease. In: Katsambas AD, Lotti T (eds) European Handbook of Dermatological Treatments. Springer, Berlin Heidelberg New York, pp 21-30
  3. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Wollina U, Stadler R, Gollnick HPM, Hölzle E, Proksch E, Söhnchen R, Keitzer R, Fritz K, Gross GE, Borgmann H, Glosemeyer R, Orfanos CE (2001) Adamantiades-Behçet’s disease: Epidemiology in Germany and in Europe. In: Lee S, Bang D, Lee E-S, Sohn S (eds) Behçet’s Disease. A Guide to its Clinical Undestanding. Textbook and Atlas. Springer, Berlin Heidelberg, pp 157-169
  4. Orfanos CE, Garbe C in Kooperation mit Blume-Peytavi U, Geilen CC, Goerdt S, Gollnick H, Haneke E, Köhn F-M, Tebbe B, Treudler R, Zouboulis CC (2002) Therapie der Hautkrankheiten einschließlich Allergologie, Andrologie, Phlebologie, Proktologie, Trichologie, pädiatrische Dermatologie, tropische Dermatosen, Venerologie und HIV-Infektion sowie dermatologische Notfälle. 2. Ausgabe. Springer, Berlin Heidelberg New York
  5. Zouboulis CC (2003) Adamantiades-Behçet's disease. In: Katsambas AD, Lotti TM (eds) European Handbook of Dermatological Treatments. 2nd edition. Springer, Berlin Heidelberg, pp 16-26
  6. Zouboulis CC (2003) Morbus Adamantiades-Behçet. In: Mrowietz U (Hrsg) Ciclosporin in der Dermatologie. Thieme, Stuttgart, S 38-51
  7. Zouboulis CC (2008) Adamantiades-Behçet disease. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick's Dermatology in General Medicine. 7th ed, McGraw Hill, New York Chicago, pp 1620-1626
  8. Zouboulis CC (2011) Adamantiades-Behçet disease. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K(eds) Fitzpatrick's Dermatology in General Medicine. 8th ed, McGraw Hill, New York Chicago, in Druck

 

Symposium-Proceedings und andere Beiträge

  1. Zouboulis CC, Büttner P, von Keyserlingk-Eberius H-J, Djawari D, Kirch W, Keitel W, Ochsendorf F, Tebbe B, Orfanos CE (1992) Morbus Adamantiades-Behçet in Deutschland. In: Forschungskommission des Universitätsklinikums Steglitz (Hrsg) Wissenschaftswoche 1992. UKS der Freien Universität Berlin, S 366-367
  2. Kienbaum S, Zouboulis CC, Waibel M, Orfanos CE (1993) Chemotactic neutrophilic vasculitis: a new histopathological pattern of vasculitis found in mucocutaneous lesions of patients with Adamantiades-Behçet’s disease. In: Wechsler B, Godeau P (eds) Behçet’s disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 337-341
  3. Kienbaum S, Zouboulis CC, Waibel M, Orfanos CE (1993) Papulopustular skin lesions in Adamantiades-Behçet’s disease show a similar histopathological pattern as the classical mucocutaneous manifestations. In: Wechsler B, Godeau P (eds) Behçet’s disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 331-336
  4. Treudler R, Zouboulis CC, Büttner P, Detmar M, Orfanos CE (1993) Alterations of lymphocyte subsets in patients with Adamantiades-Behçet’s disease and enhanced lymphocyte interaction with human dermal microvascular endothelial cells and human keratinocytes in vitro. In: Wechsler B, Godeau P (eds) Behçet’s disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 41-44
  5. Zouboulis CC, Büttner P, Djawari D, Kirch W, Keitel W, von Keyserlingk-Eberius H-J, Orfanos CE (1993) HLA-class I antigens in german patients with Adamantiades-Behçet’s disease and correlation with clinical manifestations. In: Wechsler B, Godeau P (eds) Behçet’s disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 175-180
  6. Zouboulis CC, Büttner P, Tebbe B, Orfanos CE (1993) Adamantiades-Behçet’s disease and anticardiolipin antibodies. In: Wechsler B, Godeau P (eds) Behçet’s disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 115-118
  7. Zouboulis CC, Djawari D, Kirch W, Keitel W, Ochsendorf F, Orfanos CE (1993) Adamantiades-Behçet’s disease in Germany. In: Wechsler B, Godeau P (eds) Behçet’s disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 193-196
  8. Zouboulis CC, Treudler R, Orfanos CE (1993) Systemic recombinant interferon-alpha-2a in the treatment of mucocutaneous Adamantiades-Behçet’s disease. In: Wechsler B, Godeau P (eds) Behçet’s disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 679-682
  9. Jockers-Scherübl M, Zouboulis C, Boegner F, Hellweg R (1995) Nerve growth factor, ein Serummarker für neurologische und psychiatrische Komplikationen des Morbus Behçet? In: Fromm M (Hrsg) Jahrbuch 1995. Band 2, Wissenschaftliche Kurzartikel. Fachbereich Humanmedizin, Universitätsklinikum Benjamin Franklin, S 200-201
  10. Treudler R, Ketteler R, Orfanos CE, Zouboulis CC (1996) Morbus Adamantiades- Behçet: Erhöhte Serumwerte für Interleukin-1-beta und Basischen Fibroblasten-Wachstumsfaktor. In: Fromm M (Hrsg) Jahrbuch 1996. Band 2, Wissenschaftliche Kurzartikel. Fachbereich Humanmedizin, Universitätsklinikum Benjamin Franklin, S 276-277
  11. Jockers-Scherübl MC, Zouboulis CC, Boegner F, Hellweg R (1997) Is the cytokine nerve growh factor a marker for neurological and psychiatric complications in Behçet’s disease? In: Hamza M (ed) Behçet’s Disease. Pub Adhoua, Tunis, pp 317-319
  12. Ketteler R, Treudler R, Orfanos CE, Zouboulis CC (1997) Endothelial cells secrete interleukin-8 after stimulation with serum of patients with Adamantiades-Behçet´s disease. In: Hamza M (ed) Behçet’s Disease. Pub Adhoua, Tunis, pp 92-95
  13. Treudler R, Orfanos CE, Zouboulis CC (1997) Increased serum levels of interleukin 1-beta and basic fibroblast growth factor in severe Adamantiades-Behçet’s disease. In: Hamza M (ed) Behçet’s Disease. Pub Adhoua, Tunis, pp 33-37
  14. Treudler R, Orfanos CE, Zouboulis CC (1997) Juvenile Adamantiades-Behçet’s disease in Germany. In: Hamza M (ed) Behçet’s Disease. Pub Adhoua, Tunis, pp 130-133
  15. Zouboulis CC (1997) Aphthöse Schleimhauterkrankungen. Med-Report 21(19):2-3
  16. Zouboulis CC (1997) Aphthöse Schleimhauterkrankungen. Derm - Praktische Dermatologie 3:518-522
  17. Zouboulis CC, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Licht A, Wollina U, Soehnchen R, Proksch E, Weber H, Orfanos CE (1997) Adamantiades-Behçet’s disease in Germany. Data of the German Registry in 1996. In: Hamza M (ed) Behçet’s Disease. Pub Adhoua, Tunis, pp 180-185
  18. Zouboulis CC, Orfanos CE (1997) Systemic interferon-alpha in the treatment of Adamantiades-Behçet’s disease - A review. In: Hamza M (ed) Behçet’s Disease. Pub Adhoua, Tunis, pp 441-446
  19. Adler YD, Jivanjee A, Krause L, Jovanovic S, Orfanos CE, Zouboulis CC (2001) Adamantiades-Behçet's disease with inner ear involvement. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 535-538
  20. Adler YD, Krause L, Hoffmann F, Orfanos CE, Foerster MH, Zouboulis CC (2001) Treatment of ocular Adamantiades-Behçet's disease with interferon-alpha. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 446-447
  21. Adler YD, Orfanos CE, Zouboulis CC (2001) Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 473-475
  22. Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis CC (2001) Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, p 155
  23. Katsantonis J, Adler YD, Orfanos CE, Zouboulis CC (2001) Adamantiades-Behçet's disease: Serum interleukin-8 is a more reliable marker for disease activity than c-reactive protein and erythrocyte sedimentation rate. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 129-131
  24. Katsantonis J, Seltmann H, Wróbel A, Adler YD, Hornemann S, Orfanos CE, Zouboulis CC (2001) Xenobiotic regulation of endothelial intracellular and secreted interleukin-8 induced by serum of patients with Adamantiades-Behçet's disease. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 236-239
  25. Ketteler R, Treudler R, Orfanos CE, Zouboulis CC (2001) Induction of IL-8 secretion and ICAM-1 expression by serum of patients with Adamantiades-Behçet's disease in immortalized human dermal microvascular endothelial cells in vitro is not regulated by IL-1beta or TNF-alpha. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, p 746
  26. Kötter I, Günaydin I, Yazici H, Zouboulis CC, Adler Y, Steiert I, Wernet D, Braun B, Müller C (2001) Comparative analysis of the association of HLA-B*51x and its subtypes with Behçet's disease in German Caucasians and Turkish patients. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 94-97
  27. Meljanac N, Dippel E, Zouboulis CC (2001) Superimposed primary chancre in a patient with Adamantiades-Behçet's disease. Rev Series Rheumatol 2:18-19
  28. Pfrommer C, Hadlich SF, Kohl PK, Zouboulis CC (2001) Bipolar aphthosis Neumann: A report on two cases. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, p 659
  29. Pfrommer C, Meljanac N, Zouboulis CC (2001) Superimposed primary chancre in a patient with Adamantiades-Behçet's disease. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, p 660
  30. Treudler R, Kaklamani E, Ketteler R, Kaklamanis P, Tebbe B, Zouboulis CC (2001) Interleukin-8 is increased in patients with active, mucocutaneous Adamantiades-Behçet's disease. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, p 714
  31. Treudler R, Radenhausen M, Tebbe B, Orfanos CE, Zouboulis CC (2001) Helicobacter pylori in Adamantiades-Behçet's disease: Current knowlegde and seroprevalence in an international group of patients. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 533-534
  32. Zouboulis CC (2001) Epidemiology of Adamantiades-Behçet's disease. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 43-47
  33. Zouboulis CC (2001) Genitoanal lesions in Adamantiades-Behçet's disease. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 269-272
  34. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis Ph, Orfanos CE (2001) Adamantiades-Behçet's disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 231-235
  35. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stadler R, Wollina U, Proksch E, Soehnchen R, Weber H, Gollnick HPM, Hölzle E, Fritz K, Licht Th, Orfanos CE (2001) Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. In: Bang D, Lee E-S, Lee S (eds) Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Library of Congress Cataloging, Seoul, pp 576-580
  36. Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N (2003) Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 525-528
  37. Kötter I, Günaydin I, Treusch M, Zierhut M, Kanz L, Stübiger N (2003) The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 503-509
  38. Kötter I, Vonthein R, Günaydin I, Müller C, Kanz L, Zierhut M, Stübiger N (2003) Behçet's disease in patients of German and Turkish origin - A comparative study. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 53-58
  39. Kötter I, Zierhut M, Eckstein A, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Kanz L, Stübiger N (2003) Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 521-523
  40. Krause L, Turnbull JR, Pleyer U, Torun N, Hartmann Chr, Zouboulis CC, Foerster MH (2003) Treatment of ocular Adamantiades-Behçet's disease with interferon-alpha. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 511-519
  41. Müller CA, Günaydin I, Stübiger N, Yazici H, Fresko I, Zouboulis CC, Adler Y, Steiert I, Kurz B, Wernet D, Braun B, Kötter I (2003) Association of HLA-B51 suballeles with Behçet's disease in patients of German and Turkish origin. In: Zierhut M, Ohno S (eds) Immunology of Behçet's Disease. Swets & Zeitlinger, Lisse, pp 121-126
  42. Siepmann M, Kirch W (2003) Sensory symptoms in Behçet's syndrome. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 383-384
  43. Stübiger N, Besch D, Deuter CM, Zierhut M, Kötter I (2003) Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 529-532
  44. Treusch M, Stübiger N, Vonthein R, Baur M, Koch S, Günaydin I, Kanz L, Zierhut M, Kötter I (2003) Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 533-535
  45. Turnbull JR, Tunsch A, Adler YD, Lehmann L, Borgmann H, Zouboulis CC (2003) Cardiac manifestations in four patients with Adamantiades-Behçet's disease. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 423-426
  46. Zouboulis CC (2003) Epidemiology of Adamantiades-Behçet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behçet's Disease. Swets & Zeitlinger, Lisse, pp 1-16
  47. Zouboulis CC, W Keitel (2003) A historical review of Adamantiades-Behçet's Disease. In: Zouboulis ChC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 7-14
  48. Zouboulis CC, Kötter I, Djawari D, Stadler R, Kirch W, Wollina U, Kohl PK, Keitel W, Ochsendorf FR, Gollnick HPM, Borgmann H, Turnbull JR, Keitzer R, Pleyer U, Hölzle E, Proksch E, Söhnchen R, Blech H, Glosemeyer R, Gross GE, Hoch Y, Jung EG, Koch G, Pfeiff B, Reichrath U, Schaffartzik W, Weber H, Fritz K, Orfanos CE. Current epidemiological data from the German Registry of Adamantiades-Behçet's Disease. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 43-48
  49. Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behçet's disease. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 161-171
  50. Zouboulis CC, Turnbull JR, Martus P (2003) Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet's Disease. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 123-126
  51. Zouboulis CC, Turnbull JR, Mühlradt PF (2003) Association of Mycoplasma fermentas with Adamantiades-Behçet's disease. In: Zouboulis CC (ed) Adamantiades-Behçet's Disease. Kluwer/Plenum, London Amsterdam, pp 191-194

 

Home